Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-21,000
Closed -$756K 331
2017
Q4
$756K Sell
21,000
-13,100
-38% -$443K 0.04% 106
2017
Q3
$1.22M Buy
+34,100
New +$1.11M 0.07% 71
2015
Q2
Sell
-17,505
Closed -$875K 344
2015
Q1
$875K Buy
+17,505
New +$949K 0.05% 98
2014
Q1
Sell
-389,271
Closed -$27.9M 375
2013
Q4
$27.9M Buy
389,271
+9,226
+2% +$671K 1.76% 23
2013
Q3
$26.8M Buy
380,045
+33,184
+10% +$2.22M 1.9% 21
2013
Q2
$21.6M Buy
+346,861
New +$21.4M 1.89% 23

Other funds holding NOV

R.H. Bluestein & Co's NOV Position: Q1 2018 in Review

R.H. Bluestein & Co sold out of NOV (NOV) in Q1 2018, closing a stake of 21,000 shares — an estimated $756K sold.

R.H. Bluestein & Co first reported a position in NOV in Q2 2013 and held it in 6 quarters. The position peaked at $27.9M in Q4 2013. 588 funds tracked by Wall St. Rank hold NOV as of Q1 2018.

  • R.H. Bluestein & Co reported no remaining NOV position as of Q1 2018 after selling out during the quarter.
  • R.H. Bluestein & Co sold 21,000 NOV shares in Q1 2018, an estimated $756K.
  • R.H. Bluestein & Co first reported a position in NOV in Q2 2013 and held it in 6 quarters.
  • R.H. Bluestein & Co's NOV position peaked at $27.9M in Q4 2013.
  • 588 funds tracked by Wall St. Rank held NOV as of Q1 2018.

Based on R.H. Bluestein & Co's 13F filing for Q1 2018, filed 10 May 2018.